26 May 2013
Keywords: cancer, death, risk, label, regranex, food, drug
Article | 16 June 2008
The US Food and Drug Administration has applied an additional warning label to Regranex (becaplermin) gel, marketed by Johnson & Johnson's
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 June 2008
24 May 2013
© 2013 thepharmaletter.com